Search for Clinical Trial Results
Leukemia, Prolymphocytic - 23 Studies Found
| Status | Study |
| Active, not recruiting |
Study Name: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia Condition:
|
| Completed |
Study Name: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia Condition: Leukemia Date: 2001-07-11 Interventions: Biological: alemtuzumab |
| Completed |
Study Name: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Condition:
Date: 2005-08-02 Interventions:
|
| Active, not recruiting |
Study Name: Acalabrutinib in Combination With Obinutuzumab in Relapsed/Refractory or Untreated CLL/SLL/PLL Condition:
|
| Completed |
Study Name: AZD6738 First Time in Patient Multiple Ascending Dose Study Condition:
|
| Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias Condition:
Date: 2007-05-11 Interventions:
|
| Completed |
Study Name: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma Condition:
Date: 2000-09-11 Interventions:
|
| Completed |
Study Name: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL Condition:
|
| Completed |
Study Name: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) Condition:
|